Phospholipase A2 Activity in Herniated Lumbar Discs
| dc.contributor.author | Muriel Piperno | |
| dc.contributor.author | M.-P. Hellio Le Graverand | |
| dc.contributor.author | Pascal Reboul | |
| dc.contributor.author | Pierre Mathieu | |
| dc.contributor.author | Anne Marie Tron | |
| dc.contributor.author | Gilles Perrin | |
| dc.contributor.author | M.J. Peschard | |
| dc.contributor.author | Michel Richard | |
| dc.contributor.author | Éric Vignon | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T14:04:59Z | |
| dc.date.available | 2026-03-22T14:04:59Z | |
| dc.date.issued | 1997 | |
| dc.description | Citaciones: 64 | |
| dc.description.abstract | Disc phospholipase A2 is thought to participate in the physiopathology of sciatica and to bemodulated by nonsteroidal anti-inflammatory drug therapy. Serum phospholipase A2 is suggested as a biologic marker of disc inflammation in patients with sciatica. | |
| dc.identifier.doi | 10.1097/00007632-199709150-00001 | |
| dc.identifier.uri | https://doi.org/10.1097/00007632-199709150-00001 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/44438 | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Spine | |
| dc.source | Universidad Mayor de San Andrés | |
| dc.subject | Medicine | |
| dc.subject | Lumbar | |
| dc.subject | Anatomy | |
| dc.title | Phospholipase A2 Activity in Herniated Lumbar Discs | |
| dc.type | article |